Autoimmunity: A Functional Medicine Certification Course

What is autoimmunity?

Autoimmunity is a loss of immune tolerance, where the immune system makes antibodies against the body's own tissue proteins and begins to attack them. It is not one disease or one cause. It is a web of triggers, including food proteins, infections, chemicals, and lifestyle, acting on a genetic susceptibility, and it looks different in every patient. The condition moves through three stages, from silent antibodies to symptoms to tissue destruction. It is managed, not cured, by finding and calming each patient's specific triggers and holding them in remission as long as possible.

Why is autoimmunity so hard to treat, and what actually works?

Autoimmunity rarely has one driver, yet most care chases one. A clinician who treats only the gut, or only the metals, fixes that strand and watches the patient stay sick. The work is different: autoimmunity behaves like a web, and the job is finding which strands pull on a given patient and in what order to address them.

Why isn't autoimmunity one disease?

Autoimmunity begins when the immune system loses tolerance and makes antibodies against a human tissue protein. The target protein defines the disease. Thyroid peroxidase in Hashimoto's, myelin in multiple sclerosis, islet cells in type 1 diabetes, DNA in lupus. One patient can carry antibodies to several tissues at once, which is why a long symptom list often resolves into a single explanation.

What makes it hard is that the trigger is never one thing. Genetics set the susceptibility, and then an exposure turns it on: an infection, a food protein, a chemical, a stretch of poor sleep and stress. Dr. Kharrazian teaches clinicians to hold this as the landscape of autoimmunity, and to expect the same diagnosis to have different drivers in different people.

What are the three stages of autoimmunity?

In the silent stage, the patient has predictive antibodies but no symptoms. In the reactive stage, antibodies tie to symptoms, but the tissue still works. In the third stage, enough tissue is destroyed that a conventional diagnosis finally lands, through an abnormal MRI, a joint deformity, or a failed gland.

A patient can sit in stage one or two for ten to twenty years. They can also carry different tissues at different stages at once, a thyroid already in stage three while the joints or brain stay silent. This is the gap conventional screening misses, because standard labs flag a tissue only after it is mostly gone.

Why do antibody levels mislead so many clinicians?

Antibodies do not destroy tissue. B cells make them to tag and neutralize targets so other cells can find them. The destruction is done by T cells and natural killer cells. This changes how you read a lab. A patient at a titer of 5,000 is not necessarily worse than one at 500, and a flare in antibodies does not always mean the disease is advancing.

A falling antibody count can deceive you too. When titers drop alongside a dropping white blood cell count, the immune system may simply be more exhausted, not healthier. The course teaches clinicians to read antibodies next to the CBC, complement, and T and B cell profiles, so a suppressed immune system is never mistaken for remission.

How do foods and infections trigger autoimmunity?

Molecular mimicry is the mechanism behind many food and infection triggers. When a pathogen or food protein shares an amino acid sequence with a human tissue, the antibodies made against it also bind that tissue. Strep can cross-react with myelin. Gluten and casein cross-react with cartilage, which is why dairy and wheat flare so many rheumatoid patients.

Cross-reactivity between foods is just as practical at the bedside. A patient who reacts to cow's milk usually reacts to goat's milk, and one who reacts to salmon often reacts to other fish. Infections add two more routes. Bystander activation turns on unrelated immune cells through an aggressive cytokine response, and epitope spreading pushes the attack from one tissue protein to several. The course works through these named patterns so a clinician can read a timeline and see where a flare began.

Where do you start with an autoimmune patient?

Management organizes into three levels. Level one works through the triggers: education, lifestyle, diet, antigens, chemicals, barriers, and immune tolerance. Level two handles acute flares. Level three is pharmaceutical management, which some patients genuinely need.

The first step is almost always education, not a supplement. A patient who understands relapse, remission, and their own susceptibilities becomes a partner in the work, and many improve on that alone. After that comes sleep and stress, then diet. Sleep is not optional. A patient with an active infection driving their autoimmunity has little chance of recovery until they sleep through the night. Only then does the work move to deeper triggers, and aggressive detoxification of a fragile patient is avoided because it can flare them badly.

What can you realistically promise a patient?

Autoimmunity is managed, not cured. The honest goal is more good days: longer remissions, shorter flares, and a patient who knows how to respond when one starts. Working this way asks for comfort with immunology, patience with trial and error, and the discipline to evaluate before intervening. The Autoimmunity course builds that command across the immune mechanisms, the staging, the triggers, and the management sequence a practitioner can apply to the next complex case.

For related reading, see Maintaining Standard of Care While Using Emerging Functional Medicine Research, Explaining Non-Insurance Functional Labs to Skeptical Patients, Navigating Scope of Practice in Functional Medicine: What Practitioners Should Consider, and Chronic Environmental Triggers and Loss of Self-Tolerance: The Mechanism.